Clinical Trial Update: A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED) [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluated the effects of sitagliptin (MK0431) in combination with metformin on incretin hormone concentrations. The trial involved adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED